Markku Hakala

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial

Timo Möttönen, Pekka Hannonen, Marjatta Leirisalo‐Repo et al. · The Lancet · 1999 · 868 citations

Medicine, Clinical Sciences, Pharmacotherapy +10

Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis

Andrei Călin, Ben A. C. Dijkmans, Paul Emery et al. · Annals of the Rheumatic Diseases · 2004 · 317 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +13

Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease‐modifying antirheumatic drugs: Five‐year experience from the FIN‐RACo study

Markku Korpela, Leena Laasonen, Pekka Hannonen et al. · Arthritis & Rheumatism · 2004 · 277 citations

Medicine, Internal Medicine, Pharmacotherapy +11

Early suppression of disease activity is essential for maintenance of work capacity in patients with recent‐onset rheumatoid arthritis: Five‐year experience from the FIN‐RACo trial

Kari Puolakka, Hannu Kautiainen, Timo Möttönen et al. · Arthritis & Rheumatism · 2005 · 231 citations

Medicine, Chronic Disease Control, Autoimmunity +14

Prognosis and mortality of polymyositis and dermatomyositis patients

Antti Airio, Hannu Kautiainen, Markku Hakala · Clinical Rheumatology · 2006 · 181 citations

Medicine, Immunology, Internal Medicine +10